logo
logo
AI + EXCLUSIVE DATA

AI analyzes funding data you can't access anywhere else

Our proprietary AI monitors 15,000+ companies and identifies which funded companies need YOUR specific solution right now.

10-25 personalized leads daily • 92% average intent score • Smart feed technology
Start with:
✓Flexible Plans • $39/mo or $29/mo annual
✓AI + real-time funding intelligence
✓Never see duplicates in your feed
INDUSTRY FIRST

Parse Biosciences Garners $41.5M Series B

Feb 15, 2022•over 3 years ago

Amount Raised

$41.5 Million

Round Type

series b

Description

Parse Biosciences, a provider of scalable single-cell sequencing solutions, has secured $41.5 million in Series B funding.

Company Information

Company

Parse Biosciences

About

Parse Biosciences is providing researchers with the ability to perform single cell sequencing with unprecedented scale and ease. Learn more about how you can use the most scalable single cell platform on the market without the need for custom instrumentation.

FundzWatch™ Score

72
Medium Activity

Funding Insights

Based on industry data
Tech investment trends
83% of B2B companies plan digital investments, with 79% prioritizing customer experience tech